Aging and age-related diseases – From endocrine therapy to target therapy
Authors:
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 394 (1-2) , 115-118
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Caloric Restriction Delays Disease Onset and Mortality in Rhesus MonkeysScience, 2009
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysisBMJ, 2008
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Can We Delay Aging? The Biology and Science of AgingAnnals of the New York Academy of Sciences, 2005
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Extended Longevity in Mice Lacking the Insulin Receptor in Adipose TissueScience, 2003
- IGF-1 receptor regulates lifespan and resistance to oxidative stress in miceNature, 2002
- Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone productionProceedings of the National Academy of Sciences, 2001
- Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a ?frailty gene,? not a ?longevity gene?Genetic Epidemiology, 2000